ATHXQ Projected Dividend Yield
Athersys Inc ( OTCBB : ATHXQ )Athersys is a biotechnology company that is focused primarily in the field of regenerative medicine. Co.'s MultiStem® (invimestrocel) cell therapy, a patented and proprietary allogeneic stem cell product, is its primary platform product and is in late-stage clinical development. By applying its proprietary MultiStem cell therapy product, Co. provides therapeutic product development programs treating neurological conditions, inflammatory and immune disorders, certain pulmonary conditions, cardiovascular disease and other conditions. Co.'s primary programs are focused in the critical care area, with treatment provided in hospitals often in intensive care situations. 20 YEAR PERFORMANCE RESULTS |
ATHXQ Dividend History Detail ATHXQ Dividend News ATHXQ Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |